December 14, 2007

POLYDEX PHARMACEUTICALS PROVIDES THIRD QUARTER REPORT PLANT UPGRADES LAUNCH PRODUCTION INCREASES
(continue...)

December 3, 2007

POLYDEX ANNOUNCES COMMENCEMENT OF FOLLOW-UP STUDY OF USHERCELL
(continue...)

October 1, 2007

POLYDEX MOVING FORWARD WITH CONTRACEPTIVE DEVELOPMENT AND BUILDING FOR THE FUTURE
(continue...)

September 17, 2007

FINAL REPORT OF USHERCELL AS TREATMENT FOR BACTERIAL VAGINOSIS RELEASED. ADDITIONAL TRIALS REINFORCE SAFETY AND ACCEPTABILITY
(continue...)

September 14 , 2007

POLYDEX REPORTS SECOND QUARTER FINANCIAL RESULTS
(continue...)

July 25 , 2007

ANALYSIS OF USHERCELL HIV TRIALS REVEALS DIFFERENCE IN SEROCONVERSION GROUPS NOT STATISTICALLY SIGNIFICANT POLYDEX CONTINUES CONTRACEPTIVE DEVELOPMENT
(continue...)

June 14 , 2007

POLYDEX PHARMACEUTICALS LIMITED – 2007 FISCAL YEAR END RESULTS CONTINUED GROWTH OF CORE PRODUCT SALES A PRIORITY FOR FISCAL 2008
(continue...)

April 30, 2007

POLYDEX PHARMACEUTICALS LIMITED – 2007 FISCAL YEAR END RESULTS CONTINUED GROWTH OF CORE PRODUCT SALES A PRIORITY FOR FISCAL 2008
(continue...)

February 07, 2007

POLYDEX PHARMACEUTICALS ISSUES INTERIM REPORT ON BUSINESS OPERATIONS
(continue...)

January 31, 2007

POLYDEX PHARMACEUTICALS REPORTS PHASE III TRIAL OF USHERCELL FOR HIV PREVENTION HALTED
(continue...)

December 14, 2006

POLYDEX PHARMACEUTICALS PROVIDES THIRD QUARTER REPORT WITH CONTINUED IMPROVEMENT IN SALES AND PROFIT
(continue...)

November 29, 2006

MICROBICIDES FEATURED IN NASDAQ WORLD AIDS DAY CEREMONY
(continue...)

October 3, 2006

POLYDEX PHARMACEUTICALS AWARDED FROST & SULLIVAN’S 2006 NORTH AMERICA PRODUCT INNOVATION OF THE YEAR AWARD
(continue...)

September 14, 2006

POLYDEX PHARMACEUTICALS PROVIDES SECOND QUARTER REPORT WITH IMPROVED SALES AND BOLSTERED MANAGEMENT
(continue...)

August 10, 2006

POLYDEX SPONSORS XVI INTERNATIONAL AIDS CONFERENCE SUPPORTING GLOBAL ADVOCACY OF MICROBICIDE DEVELOPMENT
(continue...)

May 15, 2006

USHERCELL CLINICAL TRIAL UPDATES PRESENTED AT INTERNATIONAL MICROBICIDE CONFERENCE
(continue...)

May 1, 2006

POLYDEX PHARMACEUTICALS LIMITED – 2006 FISCAL YEAR END RESULTS
(continue...)

January 30, 2006

POLYDEX RECEIVES EUROPEAN PATENT COVERAGE ON USE OF USHERCELL TO PREVENT AND TREAT PAPILLOMA VIRUS INFECTIONS
(continue...)

January 26, 2006

POLYDEX PHARMACEUTICALS AND CONRAD ANNOUNCE RESULTS OF USHERCELL CONTRACEPTIVE TRIAL AT PARTNERING CONFERENCE IN CALIFORNIA
(continue...)

January 23, 2006

USHERCELL ENTERS INTERNATIONAL PHASE II TRIAL FOR BACTERIAL VAGINOSIS TREATMENT AND PREVENTION
Phase III HIV Prevention trials continuing in Africa and India
(continue...)

September 14, 2005

POLYDEX PHARMACEUTICALS REPORTS SECOND QUARTER RESULTS
(continue...)

August 10, 2005

POLYDEX PROVIDES UPDATE ON USHERCELL CLINICAL TRIALS
(continue...)

June 15, 2005

POLYDEX PHARMACEUTICALS LIMITED ANNOUNCES 1ST QUARTER FINANCIAL RESULTS
(continue...)

May 3, 2005

CONRAD RECEIVES $24 MILLION FROM GATES FOUNDATION AND USAID FOR HIV MICROBICIDE TRIALS

MULTI-COUNTRY PHASE III CLINICAL TRIALS TO TEST MICROBICIDES TO PREVENT HIV INFECTION
(continue...)

May 2, 2005

POLYDEX PHARMACEUTICALS LIMITED - 2005 FISCAL YEAR END RESULTS
(continue...)

February 28, 2005

COMPANY FOUNDER AND VICE CHAIRMAN
THOMAS C. USHER
DECEASED AT AGE 90
(continue...)